MedTrace Logo

A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters

NCT00778336 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 452

Last updated 2014-10-17

Study results available
· View outcomes & findings →

Summary

This registry collects observational data about how mid-length AngioJet catheters (ie XPEEDIOR and DVX models) are used in routine clinical practice.

Conditions

  • Peripheral Vascular Diseases
  • Thrombosis
  • Venous Thrombosis

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Lawrence R. Blitz, MD · Chilton Memorial Hospital, Pompton Plains, NJ

  • Robert Lookstein, MD · Mount Sinai School of Medicine, NYC, NY

  • Eugene Simoni, MD · Samaritan Vascular Institute, Dayton, OH

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2010-03-31
Completion
2010-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00778336 on ClinicalTrials.gov